Alterations in Oral Microbiota of Differentiated Thyroid Carcinoma Patients With Xerostomia After Radioiodine Therapy

被引:8
|
作者
Lin, Baiqiang [3 ]
Zhao, Fuya [3 ,6 ]
Liu, Yang [1 ,2 ,3 ]
Sun, Jiayu [3 ,7 ]
Feng, Jing [3 ]
Zhao, Lei [3 ]
Wang, Haoran [3 ]
Chen, Hongye [3 ]
Yan, Wei [3 ]
Guo, Xiao [3 ]
Shi, Shang [3 ]
Li, Zhiyong [3 ]
Wang, Shuang [3 ]
Lu, Yu [3 ]
Zheng, Jianjun [4 ,5 ]
Wei, Yunwei [1 ,2 ,3 ]
机构
[1] Univ Chinese Acad Sci, HwaMei Hosp, Pancreat & Gastrointestinal Surg Div, Ningbo, Peoples R China
[2] Ningbo Clin Res Ctr Digest Syst Tumors, Ningbo, Peoples R China
[3] Harbin Med Univ, Affiliated Hosp 1, Oncol & Laparoscopy Surg, Harbin, Peoples R China
[4] Univ Chinese Acad Sci, HwaMei Hosp, Imaging Ctr, Ningbo, Peoples R China
[5] Ningbo Clin Med Res Ctr Imaging Med, Ningbo, Peoples R China
[6] Fujian Med Univ, Affiliated Hosp 1, Gastrointestinal Surg, Fuzhou, Peoples R China
[7] SouthernMed Univ, Zhujiang Hosp, Gen Surg, Guangzhou, Peoples R China
来源
FRONTIERS IN ENDOCRINOLOGY | 2022年 / 13卷
基金
中国国家自然科学基金;
关键词
oral microbiota; xerostomia; differentiated thyroid carcinoma; radioiodine therapy; 16S rRNA; SALIVARY-GLAND FUNCTION; RADIOACTIVE IODINE; CANCER; INFLAMMATION; LIPOPOLYSACCHARIDE; RADIATION; CAVITY;
D O I
10.3389/fendo.2022.895970
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background and AimsOral xerostomia remains one of the most common complications of differentiated thyroid carcinoma patients (DTC) after radioiodine therapy (RAI). Environmental factors in the etiology of xerostomia are largely unknown. We aimed to characterize the oral microbiota signatures and related biological functions associated with xerostomia and identify environmental factors affecting them. MethodsSaliva was collected from 30 DTC patients with xerostomia (XAs), 32 patients without xerostomia (indicated as non-XAs) following RAI after total thyroidectomy, and 40 healthy people (HCs) for 16S rRNA sequencing analysis. ResultsThe oral microbiota of XAs and non-XAs exhibited significant differences in alpha and beta diversities and bacterial taxa. The abundance of porphyromonas, fusobacterium, and treponema_2 were significantly higher in XAs, while the abundance of the streptococcus was lower in the microbiota of non-XAs. Fusobacterium, and porphyromonas were negatively correlated with unstimulated/stimulated whole salivary secretion (USW)/(SWS), while fusobacterium, porphyromonas, and treponema_2 genera levels were positively associated with cumulative radioiodine dose. PICRUSt2 and BugBase suggested a significant difference in the expression of potentially_pathogenic, anaerobic, gram_negative, the arachidonic acid metabolism, and lipopolysaccharide (LPS) biosynthesis between XAs and non-XAs, possibly interdependent on radioiodine-induced inflammation. NetShift analysis revealed that porphyromonas genus might play as a key driver during the process of xerostomia. Five genera effectively distinguished XAs from non-XAs (AUC = 0.87). ConclusionOur study suggests for the first time that DTC patients with xerostomia after RAI display microbiota profiles and associated functional changes that may promote a pro-inflammatory environment. Dysbiosis of the oral microbiota may contribute to exacerbating the severity of xerostomia. Our results provide a research direction of the interaction mechanism between oral microbiota alteration and the progress of xerostomia.
引用
收藏
页数:14
相关论文
共 50 条
  • [21] Radioiodine therapy dosimetry in benign thyroid disease and differentiated thyroid carcinoma
    Salvatori, Massimo
    Luster, Markus
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2010, 37 (04) : 821 - 828
  • [22] Radioiodine therapy dosimetry in benign thyroid disease and differentiated thyroid carcinoma
    Massimo Salvatori
    Markus Luster
    European Journal of Nuclear Medicine and Molecular Imaging, 2010, 37 : 821 - 828
  • [23] Outcome in well-differentiated follicular thyroid carcinoma after radioiodine ablation therapy
    Biermann, K.
    Brockmann, H.
    Ezziddin, S.
    Ahmadzadehfar, H.
    Haslerud, T.
    Sabet, A.
    Biersack, H. J.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2009, 36 : S451 - S451
  • [24] VALUE OF RADIOIODINE THERAPY IN THE TREATMENT OF DIFFERENTIATED THYROID-CARCINOMA
    SCHUMICHEN, C
    SCHEUFFELEN, C
    JOURNAL OF NUCLEAR MEDICINE, 1983, 24 (05) : P112 - P112
  • [25] Response to Initial Radioiodine Therapy in Pediatrics with Differentiated Thyroid Carcinoma
    Uyanik, E.
    Edis, N.
    Tamam, M. O.
    Mulazimoglu, M.
    Ozpacaci, T.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2012, 39 : S449 - S449
  • [26] Radioiodine therapy in the outcome of lung metastases in differentiated thyroid carcinoma
    Macedo, R.
    Costa, G.
    Albuquerque, A.
    Pedroso de Lima, J.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2008, 35 : S343 - S343
  • [27] A Matter of Controversy: Is Radioiodine Therapy Favorable in Differentiated Thyroid Carcinoma?
    Schmidt, Matthias
    Goerges, Rainer
    Drzezga, Alexander
    Dietlein, Markus
    JOURNAL OF NUCLEAR MEDICINE, 2018, 59 (08) : 1195 - 1201
  • [28] Correlation among ocular surface disease, xerostomia, and nasal symptoms in patients with differentiated thyroid carcinoma subjected to radioiodine therapy: A prospective comparative study
    da Fonseca, Fabricio Lopes
    Yamanaka, Patricia Kazue
    Mazoti, Luciana
    Arakawa-Sugueno, Lica
    Kato, Juliana Mika
    Matayoshi, Suzana
    HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK, 2017, 39 (12): : 2381 - 2396
  • [29] Pregnancy outcome after treatment with radioiodine for differentiated thyroid carcinoma
    Balenovic, Antonija
    Vlasic, Marko
    Sonicki, Zdenko
    Bodor, Davor
    Kusic, Zvonko
    COLLEGIUM ANTROPOLOGICUM, 2006, 30 (04) : 743 - 748
  • [30] Low dose radioiodine activity for ablation after thyroidectomy in patients with differentiated thyroid carcinoma
    Henao Celada, Y. K.
    Gomez Fernandez, I.
    Duran Barquero, C.
    Ardila Manjarres, J.
    Ardila Mantilla, J.
    Lozano Murgas, L.
    Zamudio, D.
    Rotger Regi, A.
    Alonso Farto, J.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2018, 45 : S610 - S611